250 related articles for article (PubMed ID: 30746719)
21. Urinary copper excretion and hepatic copper concentrations in liver disease.
Frommer DJ
Digestion; 1981; 21(4):169-78. PubMed ID: 7215719
[TBL] [Abstract][Full Text] [Related]
22. Pregnancy outcome after chelation therapy in Wilson disease. Evaluation of the German Embryotox Database.
Dathe K; Beck E; Schaefer C
Reprod Toxicol; 2016 Oct; 65():39-45. PubMed ID: 27350316
[TBL] [Abstract][Full Text] [Related]
23. Measurement of urinary copper excretion after 48-h d-penicillamine cessation as a compliance assessment in Wilson's disease.
Dzieżyc K; Litwin T; Chabik G; Członkowska A
Funct Neurol; 2015; 30(4):264-8. PubMed ID: 26727705
[TBL] [Abstract][Full Text] [Related]
24. Copper and zinc in the serum, urine, and hair of patients with Wilson's disease treated with penicillamine and zinc.
Dastych M; Procházková D; Pokorný A; Zdrazil L
Biol Trace Elem Res; 2010 Mar; 133(3):265-9. PubMed ID: 19562272
[TBL] [Abstract][Full Text] [Related]
25. [Wilson disease: an update].
Seo JK
Korean J Hepatol; 2006 Sep; 12(3):333-63. PubMed ID: 16998287
[TBL] [Abstract][Full Text] [Related]
26. Importance of a Liver Biopsy in the Management of Wilson Disease.
Oe S; Honma Y; Yabuki K; Morino K; Kumamoto K; Hayashi T; Kusanaga M; Ogino N; Minami S; Shibata M; Abe S; Harada M
Intern Med; 2020 Jan; 59(1):77-81. PubMed ID: 31511488
[TBL] [Abstract][Full Text] [Related]
27. Recognition, diagnosis, and management of Wilson's disease.
Brewer GJ
Proc Soc Exp Biol Med; 2000 Jan; 223(1):39-46. PubMed ID: 10632959
[TBL] [Abstract][Full Text] [Related]
28. Wilson disease - currently used anticopper therapy.
Członkowska A; Litwin T
Handb Clin Neurol; 2017; 142():181-191. PubMed ID: 28433101
[TBL] [Abstract][Full Text] [Related]
29. Wilson disease--a practical approach to diagnosis, treatment and follow-up.
Medici V; Rossaro L; Sturniolo GC
Dig Liver Dis; 2007 Jul; 39(7):601-9. PubMed ID: 17382611
[TBL] [Abstract][Full Text] [Related]
30. Response to different therapeutic approaches in Wilson disease. A long-term follow up study.
Rodríguez B; Burguera J; Berenguer M
Ann Hepatol; 2012; 11(6):907-14. PubMed ID: 23109455
[TBL] [Abstract][Full Text] [Related]
31. Relapse following withdrawal of D-penicillamine from combination (D-penicillamine + zinc) therapy in hepatic Wilson disease.
Panda K; Lal BB; Sood V; Khanna R; Alam S
J Pediatr Gastroenterol Nutr; 2024 May; 78(5):1017-1026. PubMed ID: 38695602
[TBL] [Abstract][Full Text] [Related]
32. Wilson disease.
El-Youssef M
Mayo Clin Proc; 2003 Sep; 78(9):1126-36. PubMed ID: 12962167
[TBL] [Abstract][Full Text] [Related]
33. Wilson's disease: the importance of measuring serum caeruloplasmin non-immunologically.
Walshe JM;
Ann Clin Biochem; 2003 Mar; 40(Pt 2):115-21. PubMed ID: 12662398
[TBL] [Abstract][Full Text] [Related]
34. Long-term exclusive zinc monotherapy in symptomatic Wilson disease: experience in 17 patients.
Linn FH; Houwen RH; van Hattum J; van der Kleij S; van Erpecum KJ
Hepatology; 2009 Nov; 50(5):1442-52. PubMed ID: 19731238
[TBL] [Abstract][Full Text] [Related]
35. Clinical considerations for an effective medical therapy in Wilson's disease.
Weiss KH; Stremmel W
Ann N Y Acad Sci; 2014 May; 1315():81-5. PubMed ID: 24754532
[TBL] [Abstract][Full Text] [Related]
36. Wilson Disease: Diagnosis, Treatment, and Follow-up.
Schilsky ML
Clin Liver Dis; 2017 Nov; 21(4):755-767. PubMed ID: 28987261
[TBL] [Abstract][Full Text] [Related]
37. Treatment of Wilson's disease: what are the relative roles of penicillamine, trientine, and zinc supplementation?
Schilsky ML
Curr Gastroenterol Rep; 2001 Feb; 3(1):54-9. PubMed ID: 11177695
[TBL] [Abstract][Full Text] [Related]
38. Urinary excretion of copper, zinc and iron with and without D-penicillamine administration in relation to hepatic copper concentration in dogs.
Fieten H; Hugen S; van den Ingh TS; Hendriks WH; Vernooij JC; Bode P; Watson AL; Leegwater PA; Rothuizen J
Vet J; 2013 Aug; 197(2):468-73. PubMed ID: 23583003
[TBL] [Abstract][Full Text] [Related]
39. Value of urinary copper excretion after penicillamine challenge in the diagnosis of Wilson's disease.
Martins da Costa C; Baldwin D; Portmann B; Lolin Y; Mowat AP; Mieli-Vergani G
Hepatology; 1992 Apr; 15(4):609-15. PubMed ID: 1551638
[TBL] [Abstract][Full Text] [Related]
40. Effect of D-penicillamine on liver fibrosis and inflammation in Wilson disease.
Kazemi K; Geramizadeh B; Nikeghbalian S; Salahi H; Bahador A; Reza Nejatollahi SM; Dehghani SM; Dehghani M; Kakaei F; Malek-Hosseini SA
Exp Clin Transplant; 2008 Dec; 6(4):261-3. PubMed ID: 19338486
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
